Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

First Asia-Pacific hospital treats patients with RayStation and Radixact

First Asia-Pacific hospital treats patients with RayStation and Radixact

Accuray Incorporated – Thailand’s Lopburi Cancer Hospital, a center of excellence for cancer treatment, is the first in the Asia-Pacific region to clinically use the combination of RaySearch’s treatment planning system RayStation® with Accuray’s Radixact® Treatment Delivery System.

Lopburi has a focus on innovation and has been designated a national center of excellence for cancer treatment. Today it provides specialist treatment to patients in twelve provinces around the country. The hospital selected RayStation as its treatment planning system in 2015, largely due to the system’s automated breast planning capabilities and unique multi-criteria optimization. Since its implementation, RayStation has enhanced the clinic’s workflows, reduced calculation times and ensured consistently high-quality treatment plans.

The Lopburi team, led by Dr. Kriengkri Namthaisong, hospital director and Mr. Somsak Khaunchana, head of medical physics, recently installed the Radixact System, an innovative radiation therapy device that combines integrated CT imaging with a unique helical delivery platform enabling the delivery of radiation from 360 degrees around the patient. It can target a wide range of tumors, including those in the abdomen, brain, breast, lung and head & neck. Treatment accuracy and precision are achieved through daily 3D image guidance that helps ensure proper patient positioning and accurate dose delivery to the target even when anatomical changes occur.

Click to View the full Interview with the team of Lopburi Cancer Hospital, conducted by HHM Global

Sutthisak Kulpisitthicharoen, M.D., radiation oncologist at Lopburi Cancer Hospital, says: “RayStation is easy to use and enables highly accurate treatment planning. We appreciate the multi-criteria optimization functionality, which is fast and gives the planner many possibilities. Contouring is precise and convenient, and the fallback planning feature means we can transfer treatment to an alternative machine if needed, without the need to re-plan. RayStation and Radixact are highly innovative systems, and the combination is excellent, particularly for complex cases.”

Chonthon Phihuasuth, medical physicist at Lopburi Cancer Hospital, says: “Using RayStation and Radixact together improves treatment accuracy. The synergies between these innovations will reduce time both in treatment planning and treatment delivery, as well as increase efficiency. Radixact planning in RayStation enables us to achieve highly conformal dose distributions with lower doses to organs at risk, resulting in effective treatment with fewer complications for patients.”

Johan Löf, founder and CEO of RaySearch, says: “Lopburi Cancer Hospital is a forward-looking center with a commitment to improve care through the latest technology. We are very pleased to support their planning needs for Accuray’s advanced Radixact System. The synergies between the two systems bring great benefits for patients, as well as improving workflow efficiency for the clinic.”

Joshua H. Levine, president and CEO at Accuray, says: “The Lopburi Cancer Hospital is raising the bar for other centers providing radiation therapy treatments. The clinical team’s decision to treat cancer patients using the combination of RayStation and Radixact will expand access to state-of-the-art cancer treatment technologies for the people of Thailand. Together, RayStation and Radixact provide capabilities that align well with the hospital’s goal of delivering the most effective treatments possible.”

We interviewed Birgit Fleurent, Chief Marketing Officer, Accuray Incorporation on this development, click to view the full interview here.

About Lopburi Cancer Hospital
Lopburi Cancer Hospital is a leading facility in the Mueang district of Thailand and has been designated a national center of excellence. The center is a pioneer of advanced technology and treats patients from provinces around the country using techniques such as TomoTherapy® as well as conventional radiation therapy.

About RayStation
RayStation is a flexible, innovative treatment planning system, chosen by many of the leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for IMRT and VMAT optimization with highly accurate dose engines for photon, electron, proton and carbon ion therapy. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare, the next-generation oncology information system. By harmonizing the treatment planning, we enable better care for cancer patients worldwide.

About RaySearch
RaySearch is a medical technology company that develops innovative software solutions to improve cancer care. The company markets the RayStation treatment planning system and RayCare®*, the next-generation oncology information system, worldwide. Over 2,600 clinics in more than 65 countries use RaySearch software to improve life and outcomes for patients. The company was founded in 2000 and the share has been listed on Nasdaq Stockholm since 2003.

Medtronic Receives FDA Breakthrough Device Designation for Developing Fully Implantable Heart Pump

acute myocardial infarction

Medtronic plc , the global leader in medical technology, announced it has received Breakthrough Device designation from the U.S. FDA for the Medtronic Fully Implantable Left Ventricular Assist Device (LVAD) for patients with advanced heart failure, currently in development.

Currently, LVAD systems include an implanted heart pump to increase the amount of blood that circulates through the body. The pump is connected to a driveline cable that extends outside the body to a controller, which is connected to power sources (AC or DC adapter, batteries). The future system is designed to be fully implanted inside the body.

The FDA Breakthrough Device Program is intended to help patients receive more timely access to breakthrough technologies that have the potential to provide more effective treatment or diagnosis for life-threatening or irreversibly debilitating diseases or conditions. Under the program, the FDA will provide Medtronic with priority review and interactive communication regarding device development and clinical trial protocols, through to commercialization decisions.The Medtronic Fully Implantable LVAD is in early-stage research and development, and is not available for sale anywhere in the world.

In collaboration with leading clinicians, researchers and scientists worldwide, Medtronic offers the broadest range of innovative medical technology for the interventional and surgical treatment of cardiovascular disease and cardiac arrhythmias. The company strives to offer products and services of the highest quality that deliver clinical and economic value to healthcare consumers and providers around the world.

About Medtronic
Medtronic plc , headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Wanda Group, UPMC to develop and co-manage network of international hospitals in China

Wanda Group, UPMC to develop and co-manage network of international hospitals in China

Wanda Group, one of the largest conglomerates in China, and UPMC, a leading, U.S.-based academic medical center, broke ground in Chengdu on the first of what is expected to be a network of hospitals in major cities across China. Financed by Wanda, the Chengdu hospital is expected to meet the highest international quality standards when it opens in three years.

As co-manager of the new hospital in China’s fourth-largest city, UPMC is providing its expertise in hospital design, clinical operations, technology and management to ensure a patient- and family centric experience, while creating a model that will be used to start construction on the other facilities over the next five years.

“With its global reputation for clinical excellence and more than 20 years of hands-on international operating experience, UPMC is the perfect partner to make Wanda a leader in delivering international-quality health care throughout China,” said Wang Jianlin, chairman of Wanda Group. “It’s particularly fitting that my birthplace should be the starting point for Wanda’s investment into the health and well-being of China’s citizens and for this visionary effort with UPMC.”

Added Jeffrey Romoff, chief executive officer and president of UPMC: “This partnership goes far beyond a traditional joint venture. Our first-of-its-kind network will become the largest presence of American-style academic medicine outside of the United States. Wanda-UPMC hospitals will be operated as part of our world-renowned health system, offering the most advanced and compassionate care and fueled by cutting-edge research.”

Wanda Group is one of the world’s largest diversified conglomerates, encompassing multiple ventures in real estate, film, children’s entertainment and education, professional and amateur sports, sports broadcasting, hotel management and tourism, as well as the world’s largest chain of cinemas. Wanda’s diversification into health care is guided by the national government’s “Healthy China 2030″ policy, encouraging private investment to supplement the public hospital system so that patients can get the best care close to home.

Under the agreement for Chengdu Wanda-UPMC International Hospital, expected to open in 2022, UPMC is responsible for hiring key hospital leaders, including the chief executive officer, chief nursing officer and physicians leading clinical departments. UPMC also will train staff in China and Pittsburgh — as well as in UPMC’s international locations in Ireland and Italy — while certain qualified Chengdu Wanda physicians may be considered for adjunct faculty positions at the University of Pittsburgh School of Medicine, UPMC’s academic partner.

The creation of this first hospital in Chengdu will fill a gap for state-of-the-art, patient-focused care in western China,” said Charles Bogosta, president of UPMC International and UPMC Hillman Cancer Center. “Our 20-year cooperation agreement with Wanda, reached last November, will help not only local patients but also those from other parts of the country and beyond. At the same time, this new partnership will strengthen our global network of physicians, researchers and staff as we advance excellence and innovation in health care for all of the communities we serve.”

Affiliated with the University of Pittsburgh, one of the top five recipients of research grants from the U.S. National Institutes of Health, UPMC is world-renowned in such specialties as transplantation, cancer, neurosurgery, cardiology, concussion and others for both adults and children. With more than two decades of experience building and managing health care facilities and services internationally, UPMC works with government and private partners in Italy, Ireland, Kazakhstan and China to offer patients the best possible care close to home.

Siemens Healthineers completes Corindus acquisition

Siemens Healthineers AG completed the acquisition of 100 percent of Corindus Vascular Robotics, Inc. effective October 29, 2019. Prior to the closing of the acquisition, Corindus held a shareholders’ meeting on October 25, 2019, at which 87.5 percent of their stockholders approved the acquisition. The relevant governmental authorities previously granted the approvals required to complete the acquisition.

“With the completion of the acquisition, we are opening up a new field for our Advanced Therapies business, tapping into adjacent growth markets with great potential for the future. We are taking an important step forward in the upgrading phase of our 2025 strategy,” said Bernd Montag, CEO of Siemens Healthineers AG.

“The combination of Siemens Healthineers’ strong medical technology portfolio with its digital platforms and solutions, together with Corindus’ precision robotics platform, has the potential to transform healthcare delivery so that, together, we can provide better care at lower cost,” said Mark J. Toland, former President and Chief Executive Officer of Corindus. Mr. Toland will continue to manage the business within Siemens Healthineers.

Corindus is now part of the Advanced Therapies reporting segment. Headquartered in Waltham, Massachusetts, the company develops, produces and sells a robotic-assisted platform. It is currently the only FDA cleared and CE marked robotic system for endo-vascular coronary and peripheral vascular interventions. It helps physicians to precisely control guide catheters, guide wires, balloon or stent implants via integrated imaging. The physician does not have to stand directly at the angiography table as is current practice but can control the procedure with a separate controlling module and is therefore exposed to less radiation.

Robotic assisted minimally invasive procedures have the potential to reduce treatment times, increase precision during treatment, raise standardization levels in clinical procedures and ultimately improve clinical outcomes. Corindus is currently one of the leading companies offering a robotic treatment platform for major vascular therapeutic markets.

About Siemens Healthineers
Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services.

In fiscal 2018, which ended on September 30, 2018, Siemens Healthineers generated revenue of €13.4 billion and adjusted profit of €2.3 billion and has about 50,000 employees worldwide.
Further information is available at .

Uber partners with DocsApp to provide free doctor consultations to driver-partners

Uber partners with DocsApp to provide free doctor consultations to driver-partners

Uber has partnered with DocsApp to avail free doctor consultations, subsidised prescription medicines and lab tests, for its driver and delivery partners across Uber rides and Uber Eats platforms. Under this partnership, Uber driver and delivery partners will be able to get medical assistance at a nominal cost for self and up to 5 family members.

Health is of paramount importance. Understanding this, Uber India and DocsApp will provide easily accessible healthcare facilities to the driver & delivery partners on the Uber platform. Through this partnership, driver-partners can get access to free unlimited consultation from doctors on call, along with up to 20% discount on medicines and up to 40% discount on lab tests anywhere in India.

Commenting on the partnership, Mr Pavan Vaish, Head of Central Operations (Rides), India SA, said “There can be no Uber without our driver & delivery partners. Their safety, health and overall wellbeing is our top priority. We are delighted to announce our partnership with DocsApp which aims to enhance the quality of life of our driver-partners, and their families, by providing them with increased access to medical consultations. Backed with this partnership, we believe our driver-partners will be better equipped to deliver their best when driving on our platform”.

Over 50,000 Uber India driver-partners have already registered on the online doctor consultation platform. Additionally, the drivers will be sent a pre-recorded message to help them avail the services, and they will have a separate customer support number for this.

Predictive analytics could keep more aged care residents out of Emergency

Predictive analytics could keep more aged care residents out of Emergency

New software to analyse the clinical data of aged care residents for signs of deteriorating health could reduce the number of emergency hospitalisations and allow more time for enacting end of life plans.

This clinical decision support is being developed as part of Telstra Health’s residential aged care software suite over the next two years in a $1 million partnership announced this week by RMIT University, Telstra Health and the Digital Health Cooperative Research Centre.

Significantly, it will mark the introduction of clinical decision support to predict deterioration – already used in acute care settings – into aged care.

Dr Victor Pantano, CEO of the Digital Health CRC, said the project had enormous potential to keep more aged care residents out of avoidable emergency care, as well as to provide earlier indications when residents are approaching end of life.

“Emergency hospitalisations are not only stressful for aged care residents and their families, but they also place significant additional demand on hospitals,” Dr Pantano said.

“To be able to treat residents earlier, and avert the need for hospitalisation, is extremely important.”

“Similarly, the earlier we can ascertain that an aged care resident is approaching end of life, the earlier we can enact their advance care plan and honor their preferences – an important process for the aged care resident, their carers and families, and the aged care provider.”

Importantly for aged care providers, better prediction of care needs is expected to enable more effective staffing and clinical resource planning, which has been identified as a crucial factor by providers who use Telstra Health’s aged care software.

RMIT Professor of Computer Science, Lawrence Cavedon, said the research team will work with gerontologists and aged care staff to interpret historical data and develop new predictive analytics techniques, as well as adapting existing decision support methods from the acute care sector.

“Researchers will work closely with clinicians to understand reliable signs of patient deterioration, how this might be identified from recorded data, and to manage any related ethical issues,” Professor Cavedon said.

Telstra Health has offered providers using its software to participate in the research, which has been met with a positive response from several providers.

The new algorithms will first be tested using historical data and then applied to current data in a trial setting. Ultimately, they will be integrated into Telstra Health’s Clinical and Care Management software.

Larissa Briedis from Telstra Health said the community cared deeply about the effectiveness of advanced care plans.

“While most people assume Advanced Care Directives will be enacted, the reality is that often this doesn’t occur, due to a lack of knowledge that end of life is approaching,” Ms Briedis said.

“Use of predictive analytics will enable more aged care providers, residents and their families to enact appropriate plans for end of life, according to the wishes of that person.”

As part of the Digital Health CRC’s Industry-PhD program, a PhD student will be embedded within the team.

“Through this innovative PhD program, we’re also helping build the digital health workforce Australia will need in the future,” Dr Pantano said.

The project is one of many being rolled out over the coming months through the Digital Health CRC, one of the world’s largest digital health R&D cooperatives.

Facebook launches healthcare tool for check-up reminders

Facebook launches healthcare tool for check-up reminders

Making a foray into the personal digital healthcare domain, Facebook has unveiled a ‘Preventive Health’ tool that connects people to health resources and sends check-up reminders.

Launched first in the United States, the tool is designed to help users of the social networking giant to find affordable places to receive care, set reminders to schedule tests and mark when tests are completed.

“Our initial focus is on the top two leading causes of death in the US: heart disease and cancer, (according to CDC) as well as the flu, a seasonal illness that affects millions each year,” Freddy Abnousi, Facebook’s Head of Healthcare Research said in a blog post on Monday.

The resources available in the tool are provided by the American Cancer Society, the American College of Cardiology, the American Heart Association and the Centres for Disease Control and Prevention. The recommendations to the users will be provided on the basis on their age and sex.

“In the US, people can search for Preventive Health in the Facebook mobile app and find out which check-ups, such as cholesterol tests or mammograms, are recommended by these health organisations based on the age and sex they provide,” Abnousi said. “Reminders for flu shots will also appear at the appropriate time of year,” he added.

Facebook said it would now show ads based on the information users provide in Preventive Health. “Personal information about your activity in Preventive Health is not shared with third parties, such as health organisations or insurance companies, so it can’t be used for purposes like insurance eligibility,” Abnousi said.

Facebook earlier launched a feature in India, Brazil, Bangladesh, Pakistan, and the US that makes it easy to sign up as a blood donor on Facebook and get notified when nearby blood banks are in need.

“So far, more than 50 million people have signed up to donate,” Abnousi said. “According to our blood bank partners in India and Brazil, 20 per cent of voluntary, walk-in blood donors are coming from Facebook,” he added.

The 5 Most Promising Medical Careers for 2020

The 5 Most Promising Medical Careers for 2020

The medical field is one that will always be necessary. People will always need medical care, whether it’s because they’ve become ill, gotten injured or are just aging. What changes are the specialties that need the newest graduates to keep them running smoothly.

With that in mind, consider the following five most promising medical careers as we move into 2020 if you’re interested in changing your career or field in the coming year.

1. Dental Hygienist
If you’re looking at medical career options, you might not typically think of including dentistry in your search. But if you overlook the possibility of becoming a dental hygienist, you’ll be doing yourself a great disservice.

This is one medical field you can tackle with as little as an associate’s degree — no need to spend years in schools or accrue tens of thousands of dollars in student debt. The average dental hygienist’s program will take three years to complete, including obtaining the necessary licensing to practice in your state.

According to the Bureau of Labor Statistics (BLS), the average dental hygienist makes just under $75,000 a year, or $36 an hour. This field is projected to grow much faster than average — 11% — between 2018 and 2028, adding more than 23,000 new positions in the next 10 years.

2. Respiratory Therapist
Respiratory therapists specialize in treatment and care for individuals who experience breathing problems, like those with COPD, asthma and similar conditions. A job in this field is usually a full-time position, and the field is expected to grow 23% between 2016 and 2026, according to the BLS.

The average respiratory therapist needs an associate’s degree, though some will work through a four-year bachelor’s degree program instead. The reported median pay for these specialists in 2018 was $60,280 a year, or $28.98 per hour.

Respiratory therapy is easily one of the fastest-growing fields in medicine, so now is the perfect time to make the switch to that specialty or start a respiratory therapy program at your local college.

3. Radiologic Technologist
While radiologic technologists might not examine diagnostic imagery to make a diagnosis, they’re a vital part of the diagnostic process, managing all the equipment necessary to take X-rays, MRIs, CT scans and more. Radiologic technicians have the benefit of being able to work anywhere that uses imaging equipment, from hospitals and outpatient facilities to research labs and even veterinary medicine.

While this field isn’t growing as fast as some of the other careers on this list — only nine percent between 2018 and 2028, according to the BLS — a radiologic technologist can expect to enjoy an average median salary of $56,670 and up.

Becoming a radiologic technologist requires only an associate’s degree, so if you want to change your career quickly, you’ve only got two to three years between you and your new career in radiology.

4. Occupational Therapy Assistant
Occupational therapists help people learn the skills they need for daily life and work while helping them recover from an injury, disability or illness. Becoming an occupational therapist requires a master’s degree, but working as an assistant to a therapist requires only an associate’s degree.

You need a two-year occupational therapy assistant’s program as well as 16 weeks of fieldwork to gain experience before you can work in the field.

According to the BLS, occupational therapy assistants are in one of the fastest-growing fields in the country, which is expected to grow an astonishing 31% between 2018 and 2028. Occupational therapy assistants make an average of $57,620 a year, and this degree program can be a fantastic stepping stone if you’re considering seeking a master’s degree in occupational therapy.

5. Dietitian or Nutritionist
The average person finds it challenging to know what to eat to ensure they’re getting the best nutrition. That’s where nutritionists and dietitians come in. Specialists in this field are trained to help people learn how to eat healthily to improve their lifestyle or reach a specific goal.
This career does require a bachelor’s degree as well as an internship or residency to be able to practice, but professionals in this field can expect to enjoy a median annual salary of $60,370, according to the BLS.

While this specific field isn’t growing as fast as those for occupational therapy assistants and respiratory therapists, it’s expected to grow by 11% between 2018 and 2028, which still makes its growth much faster than average.

Looking Toward 2020
The medical field is changing as we move closer to 2020. If you’re trying to choose your major or feeling burned out in your current field and want to look for a change, remember that these five careers are some of the fastest-growing in the country.

Do some research and see if one of them might be a good fit for you as you continue your career in medicine. Every field is necessary, but not all fields are created equal when it comes to career growth, so choose wisely.

Leidos commercial EHR consulting business acquired by ettain group

Leidos commercial EHR consulting business acquired by ettain group

Ettain group, a leading provider of talent solutions, announced that it has acquired Global Employment Solutions and Leidos Inc.’s commercial Electronic Health Records consulting business. In connection with the transactions, ettain group has received a new majority investment from Alvarez & Marsal Capital.

“ettain group provides a highly attractive platform for investment in the IT staffing and solutions space,” said Michael Odrich, Managing Partner & Founder of A&M Capital. “The company’s strong leadership and proven results position ettain group well for future growth both organically and through additional M&A.”

“We believe that the combination of these three companies immediately creates a leader in the market with a focus on in-demand IT skills and solutions,” said Alex Nivelle, a Partner of A&M Capital. “We are excited to partner with management to support the business in its next phase of growth and development.”

GES provides Information Technology and Professional staffing services in the commercial and government markets under the brands Fahrenheit IT, ITEC and Global Employment Solutions. GES employs over 1,500 professionals with office locations in 13 markets. Since 2014, GES has been a portfolio company of TZP Group. TZP and co-investors will retain a minority stake in the combined company.

Leidos Health, LLC was originally formed through the acquisitions of Vitalize Consulting Solutions and MaxIT Healthcare in 2011 and 2012, respectively, and is a market leading provider of EHR Implementation, Optimization and Go-Live services. The business has been carved out from Leidos Inc. and will be re-branded along with ettain group’s Healthcare IT practice as ettain health. Leidos Inc. retains a large Healthcare business that serves government and commercial customers.

The acquisitions will enable ettain group to further strengthen its national Healthcare IT capabilities and to grow its IT staffing presence in several strategic markets, including New York, NY, Denver, CO, and Chicago, IL. In addition, the firms’ talented teams, range of solutions and high-integrity cultures are a strong complement to ettain group’s vision to deliver an unparalleled level of quality and service.

“We’re extremely excited to join forces with these well-respected leaders in our industry,” said Trent Beekman, Chief Executive Officer of ettain group. “The Leidos Health business brings deep knowledge and comprehensive Healthcare IT advisory, implementation, optimization, and application management solutions. GES brings years of experience in IT and professional staffing and ranks among the largest U.S. staffing firms. The additional portfolios and strong client relationships will fuel the company forward into a new era of opportunity and result in a combined organization of more than 3,000 employees and consultants. Together, we look forward to continuing to enhance our capabilities, allowing us to drive our clients’ businesses forward and to positively impact the U.S. staffing industry landscape.”

A&M Capital was advised by SunTrust Robinson Humphrey and Kirkland & Ellis. NMS was advised by Houlihan Lokey and Greenberg Traurig. GES was advised by Houlihan Lokey, Brownstein Hyatt Farber Schreck, and Kirkland & Ellis. Leidos Inc. was advised by Baird and Venable.

About ettain group
ettain group is a leading talent solutions firm that delivers Recruitment Services and Managed Services in three practice areas: IT, Healthcare IT, and Digital Creative. From discovery to execution, we help our clients successfully design, develop, and deliver critical technology and business initiatives, from providing individual resources, to staffing and managing critical programs and projects, to running entire recruitment processes. Founded in 1996, with nearly 1,300 employees and consultants currently at work, we offer opportunities across North America, with offices in Charlotte, Dallas, Minneapolis, Nashville, Raleigh, Washington, D.C., and Winston Salem. For more information, visit www.ettaingroup.com.

About Alvarez & Marsal Capital
Alvarez & Marsal Capital is a multi-strategy private equity investment firm with over $3 billion in assets under management across four funds and three investment strategies. The firm is led by a highly experienced investment team, which is augmented by a strategic association with Alvarez & Marsal (“A&M”), one of the largest operationally-focused advisory firms in the world. A&M Capital combines a focus on middle-market private equity investing, with deep operational expertise, industry knowledge and global corporate relationships, making A&M Capital an attractive partner to management teams and business owners. A&M Capital is headquartered in Greenwich, CT with offices in San Francisco, CA and London, England. For more information, visit www.a-mcapital.com.

ConvergeHEALTH by Deloitte Launches New Digital Health Ecosystem Platforms at HLTH Conference

ConvergeHEALTH by Deloitte Launches New Digital Health Ecosystem Platforms at HLTH Conference

ConvergeHEALTH by Deloitte announced the launch of a robust platform for the health care ecosystem that supports two critically important patient journeys.

MyPATH for Health and MyPATH for Connected Care work together to connect and support patients and their care teams across the patient experience from clinical trials to treatment and beyond.

The MyPATH platform helps health systems, biopharmaceutical, medical device, and health plan innovators deliver next-generation patient support services and therapy management across the patient journey, improving their overall experience while cultivating a rich, real-world data set.

“Because of new interoperability standards and a growing ecosystem of connected devices, patients are increasingly in control of their health and wellness data,” said Brett Davis, principal, Deloitte Consulting LLP, and general manager, ConvergeHEALTH by Deloitte. “But to transform the patient experience — whether supporting virtual health or virtual clinical trials — the patient must be connected to a platform that supports new workflows and paradigms of delivering care and supporting clinical research. The ConvergeHEALTH MyPATH platform helps life sciences and health care organizations do just that for the patients they serve.”

MyPATH for Health
The challenges of living with a chronic or serious illness, including complex symptoms, side-effects and treatments, can make it difficult for patients to adhere to their care plans. This can lead to increased cost for care and missed opportunities to improve patients’ lives. MyPATH for Health is a digital solution that supports life science innovators for clinical trials and patient services by connecting patients, caregivers, providers and life sciences organizations. By connecting all stakeholders, MyPATH can transform patient engagement, create a connected care team, aim to improve outcomes, and cultivates a rich, real-world data set for analysis.

“There is a growing body of evidence showing the value of digital and patient engagement solutions,” said Christopher Zant, principal, Deloitte Consulting LLP, and chief digital officer, ConvergeHEALTH by Deloitte. “The shift to a patient-centric health care environment creates significant opportunity but also requires a new way of thinking and novel strategies to be successful. With MyPATH for Health, organizations are better equipped to support and empower patients to understand their health status and be their best selves.”

MyPATH for Health enables:

Care coordination
Medication and appointment reminders
Remote health and risk monitoring
24/7 support network
Novel approaches for improving research and development
ePRO and consent management for clinical trials
Community and family support

MyPATH for Connected Care

With patients at the center of the evolving health care ecosystem, business needs to meet them where they are. Making the pivot to virtual care is essential to expanding access to care, improving clinical outcomes, increasing patient engagement and reducing costs. MyPATH for Connected Care is a digital health care platform that connects patients and care teams to deliver virtual care services through an effective, data-driven experience.

“The way a patient manages their condition on a day-to-day basis, whether at home, at work and on the go, has lasting impact on their health and the question becomes how can we leverage technology to help support their health longitudinally,” said Summer Knight, managing director, Deloitte Consulting LLP, and virtual health leader, ConvergeHEALTH. “MyPATH for Connected Care seeks to answer this question by delivering high-touch customer experiences across channels by enabling personalized treatment plans, more efficient workflows, and allows clinical teams and consumers to collaborate adjusting care plans based on real-time data generated from the patient.”

MyPATH for Connected Care enables:

A connected ecosystem to support patients and care teams at every stage and setting
Continuous strategies for building capabilities that deploy patient-centered virtual home care
A robust health data collection with a focus on care plan management
A holistic, personalized approach to care plans
The ability to empower patients, with user friendly devices and wearables

About Deloitte
Deloitte provides industry-leading audit, consulting, tax and advisory services to many of the world’s most admired brands, including nearly 90% of the Fortune 500® and more than 5,000 private and middle market companies. Our people work across the industry sectors that drive and shape today’s marketplace — delivering measurable and lasting results that help reinforce public trust in our capital markets, inspire clients to see challenges as opportunities to transform and thrive, and help lead the way toward a stronger economy and a healthy society. Deloitte is proud to be part of the largest global professional services network serving our clients in the markets that are most important to them. Our network of member firms in more than 150 countries and territories serves four out of five Fortune Global 500® companies. Learn how Deloitte’s approximately 286,000 people make an impact that matters at www.deloitte.com.

1...669670671...1,125Page 670 of 1,125

About us

Hospital & healthcare Management is a leading B2B arena designed for the healthcare sector, it allow members to reach both ends of the healthcare facility procurement chain. . . Read More

Subscribe us

System

Resources

Archive Links

Subscribe

Copyright © 2008 - 2026 Hospital & Healthcare Management. All rights reserved. Publication of Leo Marcom Pvt Ltd.

Translate »